dacarbazine and at 13387

dacarbazine has been researched along with at 13387 in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Abas, FS; Beattie, CE; Canella, A; Gumin, J; Gurcan, MN; Kaur, B; Kesanakurti, D; Lang, FF; Liu, J; Nagarajan, P; Puduvalli, VK; Sampath, D; Sulman, EP; Welker, AM; Xu, J; Yoo, JY	1

Other Studies

1 other study(ies) available for dacarbazine and at 13387

Article	Year
Efficacy of Onalespib, a Long-Acting Second-Generation HSP90 Inhibitor, as a Single Agent and in Combination with Temozolomide against Malignant Gliomas. Clinical cancer research : an official journal of the American Association for Cancer Research, 2017, Oct-15, Volume: 23, Issue:20 Topics: Animals; Antineoplastic Agents; Benzamides; Blood-Brain Barrier; Cell Line, Tumor; Cell Movement; Cell Proliferation; Dacarbazine; Disease Models, Animal; Drug Synergism; Drug Therapy, Combination; ErbB Receptors; Extracellular Signal-Regulated MAP Kinases; Female; Gene Expression; Glioma; HSP90 Heat-Shock Proteins; Humans; Isoindoles; Mice; Neoplastic Stem Cells; Protein Transport; Proto-Oncogene Proteins c-akt; Ribosomal Protein S6 Kinases; Signal Transduction; Survival Rate; Temozolomide; Xenograft Model Antitumor Assays; Zebrafish	2017

Article

Year

Efficacy of Onalespib, a Long-Acting Second-Generation HSP90 Inhibitor, as a Single Agent and in Combination with Temozolomide against Malignant Gliomas.

Clinical cancer research : an official journal of the American Association for Cancer Research, 2017, Oct-15, Volume: 23, Issue:20

Topics: Animals; Antineoplastic Agents; Benzamides; Blood-Brain Barrier; Cell Line, Tumor; Cell Movement; Cell Proliferation; Dacarbazine; Disease Models, Animal; Drug Synergism; Drug Therapy, Combination; ErbB Receptors; Extracellular Signal-Regulated MAP Kinases; Female; Gene Expression; Glioma; HSP90 Heat-Shock Proteins; Humans; Isoindoles; Mice; Neoplastic Stem Cells; Protein Transport; Proto-Oncogene Proteins c-akt; Ribosomal Protein S6 Kinases; Signal Transduction; Survival Rate; Temozolomide; Xenograft Model Antitumor Assays; Zebrafish

2017